Prevalence of polypharmacy and associated adverse health outcomes in adult patients with chronic kidney disease: protocol for a systematic review and meta-analysis

BACKGROUND: Polypharmacy, often defined as the concomitant use of ≥ 5 medications, has been identified as a significant global public health threat. Aging and multimorbidity are key drivers of polypharmacy and have been linked to a broad range of adverse health outcomes and mortality. Patients with...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Syst Rev
Hlavní autoři: Okpechi, Ikechi G., Tinwala, Mohammed M., Muneer, Shezel, Zaidi, Deenaz, Ye, Feng, Hamonic, Laura N., Khan, Maryam, Sultana, Naima, Brimble, Scott, Grill, Allan, Klarenbach, Scott, Lindeman, Cliff, Molnar, Amber, Nitsch, Dorothea, Ronksley, Paul, Shojai, Soroush, Soos, Boglarka, Tangri, Navdeep, Thompson, Stephanie, Tuot, Delphine, Drummond, Neil, Mangin, Dee, Bello, Aminu K.
Médium: Artigo
Jazyk:Inglês
Vydáno: BioMed Central 2021
Témata:
Protocol
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC8256607/
https://ncbi.nlm.nih.gov/pubmed/34218816
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13643-021-01752-z
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky